A groundbreaking study reveals that weight-loss medications significantly reduce the risk of early death in heart patients.
These drugs, known as GLP-1 agonists, halve the risk of hospitalization or premature death for millions with heart conditions.
Researchers analyzed data from over 90,000 patients, demonstrating the drugs' remarkable effectiveness in improving heart health.
While further research is needed, these findings offer substantial hope for improving the lives and longevity of heart patients.
